Shareholder information

Company incorporation information

Angel Biotechnology Holdings Plc is a public limited company registered in England and Wales, registration number 05383314, registered office 50 Broadway, London SW1H OBL, United Kingdom.

Angel Biotechnology Holdings Plc was admitted to trading on AIM in November 2005 under ticker ABH. Angel is not traded on any other platform than AIM.

Articles of Association

Angel Biotechnology Holdings Plc's Articles of Association (348kb)

Major shareholders

Identity and percentage holding of shareholders with greater than 3% holding:


TD Direct Investing Nominees (Europe) Ltd	478,344,064	13.4%
Barclayshare Nominees Ltd	381,344,037	10.7%
Hargreave Hale Nominees Ltd	267,800,000	7.5%
Chase Nominees Ltd	250,000,000	7.0%
HSDL Nominees Ltd	224,041,940	6.3%
Investor Nominees Ltd	169,195,164	4.7%
James Capel (Nominees) Ltd	161,761,888	4.5%
L R Nominees Ltd	144,563,154	4.0%
Hargreaves Lansdown (Nominees) Ltd	142,428,343	4.0%

Ordinary shares in issue: 3,773,616,615

Information correct at 25 April 2012.

Share price

Share price information

Major shareholders and investor relations contact information

Angel Biotechnology Holdings Plc, (AIM: ABH), the biopharmaceutical contract manufacturer, announces that application has been made for the admission to trade on AIM of 4,803,573 ordinary shares of 0.1p ("ordinary shares") nominal value with admission expected to take place on 13 April 2011.

Corporate advisors

PLC registered office

50 Broadway
London
SW1H OBL

Registrars

Capita Registrars
Northern House
Woodsome Park
Fenay Bridge
Huddersfield
HD8 OLA

Auditors

Baker Tilly UK Audit LLP
Chartered Accountants
1 St James' Gate
Newcastle Upon Tyne
NE1 4AD

Solicitors

Bircham Dyson Bell
50 Broadway
Westminster
London
SW1H OBL

Nominated advisors

Grant Thornton UK LLP
30 Finsbury Square
London
EC2P 2YU

Brokers

Hybridan LLP
29 Throgmorton Street
London
EC2N 2AT

Can we help?

Investor relations

Bespoke solutions from clinical trial to launch